News and press releases from HAPILA
New Tuberculosis Agent Enters Clinical Trials

Scientists of two Research Associations and Enterprises Join Forces for this Purpose The first antibiotic against tuberculosis developed in Germany is now being tested in clinical trials. The newly developed test substance with...[more]
Exhibitor at Chemspec 2018 Koelnmesse Cologne

HAPILA will be present at the Chemspec Europe – 33rd International Exhibition for Fine and Speciality Chemicals – on a shared booth together with 8 other companies at hall 8 stand E78. The exhibition takes place on 20-21 June...[more]
Clinical study of pharmaceuticals for treating tuberculosis with API BTZ 043

Despite increasing infection rates the development of new antibiotics is stagnating as pharmaceutical enterprises have withdrawn from this sector to a large extent. Hence there is an increasing demand for new anti-infective...[more]
Funding project for researching and developing a GMP manufacturing process for tuberculostatics

Within the promotion of economic development and innovation by the Thüringer Aufbaubank the research and development project „Research in new synthesis cycles and development of a manufacturing process based on them in accordance...[more]
CPhI 2017 Frankfurt am Main - Meet us at 11.1 C54

"CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 42,000 visiting pharma professionals over three days. 2,500+ exhibitors from 153 countries gather at the event to network and...[more]
Chemspec Europe 31 May - 1 June 2017, Munich

The value chain of organic fine chemicals and active ingredient production at one stand Eight companies from East Germany will present their expertise together at one stand at Chemspec Europe 2017 in Munich. With their broad...[more]
API Manufacture Using Green Electricity from January

Due to the conclusion of a new energy supply contract between HAPILA GmbH and Thüringer Energie AG (TEAG), the Thuringian Energy public limited company, green current will flow at HAPILA from January 2017. Ms Annegret Noth and Mr...[more]